14 ve 18 Gauge İğnelerle Yapılan Kor İğne Meme Biyopsisi Analizlerinin Değerlendirilmesi: Sekiz Yıllık Tek Merkez Deneyimi

Abstract

Amaç: Perkutan görüntüleme eşliğinde kor iğne meme biyopsisi, meme lezyonlarının teşhisinde insizyonel biyopsiye alternatif olarak yaygın bir şekilde kullanılmaktadır. Bu çalışmada; 14 ve 18 gauge iğnelerle yapılan kor iğne meme biyopsisi deneyimlerimizin değerlendirilmesi ve sunulması amaçlanmıştır. Gereç ve Yöntemler: Bu çalışmaya, Mart 2012 ve Aralık 2019 tarihleri arasında Radyoloji Anabilim Dalında kor iğne meme biyopsisi uygulanmış olan ve biyopsi örnekleri Patoloji Anabilim Dalında değerlendirilmiş olan, tüm yaş gruplarından ve her iki cinsiyetten hastalar dahil edilmiştir. Meme lezyonu olan toplam 628 (615 kadın ve 13 erkek) hasta incelenmiştir. Bulgular: Hastaların ortalama yaşı 52.20±13.94 (medyan= 51, aralık, 13-96) yıl olup, lezyonların %90,4'ü (n=568) kitle lezyonu şeklindeydi ve lezyonların büyük çoğunluğu (53.1%; n=334) 11-20 mm boyutundaydı. Vakaların çoğu (%47,2; n=268) BI-RADS 5 idi. İki iğne arasında cinsiyet dağılımı, yaş, ameliyat türü ve kor iğne meme biyopsisi sonuçları açısından anlamlı bir farklılık yoktu. Hastaların %86,5'ünde (n=141) cerrahi olarak çıkartılan materyallerin histopatolojik sonucu ve kor iğne meme biyopsisi sonucu arasında tanısal doğruluk vardı. Sonuç: 14-gauge ve 18-gauge iğnelerin benzer sonuç gösterme potansiyeline sahip olduğu tespit edilmiştir. Daha az invaziv, daha az ağrılı ve daha az kanama olma riski içeren ultrason eşliğindeki meme biyopsileri için daha küçük iğnelerin kullanılması daha uygundur. Ayrıca, çalışma süresi içinde hematom, kanama vb. gibi akut kor iğne meme biyopsisi komplikasyonları nedeniyle hiçbir hasta acil servise başvurmamıştır.

Keywords

• Kor iğne meme biyopsisi
• meme kitleleri
• biyopsi örnekleri

The Evaluation of Core Needle Breast Biopsy Analyzes Performed with 14 and 18 Gauge Needles: A Single Center Experience for Eight Years

Abstract

Aim: Percutaneous imaging-guided core needle breast biopsy has become widely used as an alternative to incisional biopsy in the diagnosis of breast lesions. In this study, it was aimed to evaluate and report our core needle breast biopsy experiences performed with 14- and 18-gauge needles. Material and Methods: Patients who underwent core needle breast biopsy between March 2012 and December 2019 in our radiology department and whose biopsy specimens were evaluated in the pathology department, of all age groups and both sexes, were included in this study. A total of 628 (615 female and 13 male) patients with breast masses were examined. Results: The mean age of the patients was 52.20±13.94 (median= 51, range, 13-96) years, 90.4% (n=568) of the lesions were masses and the majority of lesions (53.2%, n=334) were 11-20 mm in size. The most of cases (47.2%, n=268) were BI-RADS 5. There was no significant difference between the two needles in terms of gender distribution, age, type of surgery, and core needle breast biopsy results. In 86.5% (n=141) of the patients, there was diagnostic accuracy between the surgical specimen and the core needle breast biopsy result. Conclusion: We demonstrated that the 14-gauge and 18-gauge needles have similar performance of results. Smaller needles should be used for ultrasound-guided breast biopsies, which is less invasive, less painful, and creates less risk of hemorrhage. Moreover, no patient admitted to the emergency department because of the core needle breast biopsy acute complications such as hematoma, bleeding, etc. during this time.

Keywords

• Core needle breast biopsy
• breast masses
• biopsy specimens

References

1. Cho N, Moon WK, Cha JH, Kim SM, Kim SJ, Lee SH, et al. Sonographically guided core biopsy of the breast: comparison of 14-gauge automated gun and 11-gauge directional vacuum-assisted biopsy methods. Korean J Radiol. 2005;6(2):102-9.
2. Jung I, Kim MJ, Moon HJ, Yoon JH, Kim EK. Ultrasonography-guided 14-gauge core biopsy of the breast: results of 7 years of experience. Ultrasonography. 2018;37(1):55-62.
3. Schueller G, Jaromi S, Ponhold L, Fuchsjaeger M, Memarsadeghi M, Rudas M, et al. US-guided 14-gauge core-needle breast biopsy: results of a validation study in 1352 cases. Radiology. 2008;248(2):406-13.
4. Bilous M. Breast core needle biopsy: issues and controversies. Mod Pathol. 2010;23(Suppl 2):S36-45.
5. Destounis S, Skolny MN, Morgan R, Arieno A, Murphy PF, Somerville P, et al. Rates of pathological underestimation for 9- and 12-gauge breast needle core biopsies at surgical excision. Breast Cancer. 2011;18(1):42-50.
6. Wei X, Li Y, Zhang S, Zhu Y, Fan Y. Experience in large-core needle biopsy in the diagnosis of 1431 breast lesions. Med Oncol. 2011;28(2):429-33.
7. Wu YC, Chen DR, Kuo SJ. Personal experience of ultrasound-guided 14-gauge core biopsy of breast tumor. Eur J Surg Oncol. 2006;32(7):715-8.
8. Lai HW, Wu HK, Kuo SJ, Chen ST, Tseng HS, Tseng LM, et al. Differences in accuracy and underestimation rates for 14- versus 16-gauge core needle biopsies in ultrasound-detectable breast lesions. Asian J Surg. 2013;36(2):83-8.

9. Fishman JE, Milikowski C, Ramsinghani R, Velasquez MV, Aviram G. US-guided core-needle biopsy of the breast: how many specimens are necessary? Radiology. 2003;226(3):779-82.
10. Tse GM, Tan PH. Diagnosing breast lesions by fine needle aspiration cytology or core biopsy: which is better? Breast Cancer Res Treat. 2010;123(1):1-8.
11. Bruening W, Fontanarosa J, Tipton K, Treadwell JR, Launders J, Schoelles K. Systematic review: comparative effectiveness of core-needle and open surgical biopsy to diagnose breast lesions. Ann Intern Med. 2010;152(4):238-46.
12. Neuberger J, Patel J, Caldwell H, Davies S, Hebditch V, Hollywood C, Hubscher S, et al. Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology. Gut. 2020;69(8):1382-403.
13. Rosa M, Agosto-Arroyo E. Core needle biopsy of benign, borderline and in-situ problematic lesions of the breast: Diagnosis, differential diagnosis and immunohistochemistry. Ann Diagn Pathol. 2019;43:151407.
14. Tublin ME, Blair R, Martin J, Malik S, Ruppert K, Demetris A. Prospective study of the impact of liver biopsy core size on specimen adequacy and procedural complications. AJR Am J Roentgenol. 2018;210(1):183-8.
15. Zhou JY, Tang J, Wang ZL, Lv FQ, Luo YK, Qin HZ, et al. Accuracy of 16/18G core needle biopsy for ultrasound-visible breast lesions. World J Surg Oncol. 2014;12:7.
16. Mercado CL. BI-RADS update. Radiol Clin North Am. 2014;52(3):481-7.
17. Linda A, Zuiani C, Furlan A, Lorenzon M, Londero V, Girometti R, et al. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI? AJR Am J Roentgenol. 2012;198(2):272-80.
18. Kozan R, Tokgöz VY. Screening program and breast cancer awareness in Turkey. ACU Sağlık Bil Derg. 2016;4:185-8.
19. Kılıç D, Sağlam R, Kara Ö. The examination of the factors affecting the awareness of breast cancer in college students. J Breast Health. 2009;5(4):195-9.
20. Seely JM, Hill F, Peddle S, Lau J. An evaluation of patient experience during percutaneous breast biopsy. Eur Radiol. 2017;27(11):4804-11.
21. Bick U, Trimboli RM, Athanasiou A, Balleyguier C, Baltzer PAT, Bernathova M, et al. Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging. Insights Imaging. 2020;11(1):12.
22. Hemmer JM, Kelder JC, van Heesewijk HP. Stereotactic large-core needle breast biopsy: analysis of pain and discomfort related to the biopsy procedure. Eur Radiol. 2008;18(2):351-4.
23. Lin LLY, Gao Y, Lewin AA, Toth HK, Heller SL, Moy L. Overstated harms of breast cancer screening? A large outcomes analysis of complications associated with 9-gauge stereotactic vacuum-assisted breast biopsy. AJR Am J Roentgenol. 2019;212(4):925-32.
24. Nguyen Q, Mehta SV, Fang J, Sheiman R, Kane R, Ahmed M, et al. Thirty-day emergency room visits and hospital admissions after outpatient non-vascular image-guided procedures. Abdom Radiol (NY). 2017;42(10):2538-43.
25. Giuliani M, Rinaldi P, Rella R, Fabrizi G, Petta F, Carlino G, et al. Effect of needle size in ultrasound-guided core needle breast biopsy: Comparison of 14-, 16-, and 18-gauge needles. Clin Breast Cancer. 2017;17(7):536-43.
26. McCormack M, Duclos A, Latour M, McCormack MH, Liberman D, Djahangirian O, et al. Effect of needle size on cancer detection, pain, bleeding and infection in TRUS-guided prostate biopsies: A prospective trial. Can Urol Assoc J. 2012;6(2):97-101.
27. Midia M, Odedra D, Shuster A, Midia R, Muir J. Predictors of bleeding complications following percutaneous image-guided liver biopsy: a scoping review. Diagn Interv Radiol. 2019;25(1):71-80.
28. Apesteguía L, Pina LJ. Ultrasound-guided core-needle biopsy of breast lesions. Insights Imaging. 2011;2(4):493-500.
29. Youk JH, Kim EK, Kim MJ, Oh KK: Sonographically guided 14-gauge core needle biopsy of breast masses: a review of 2,420 cases with long-term follow-up. AJR Am J Roentgenol. 2008;190(1):202-7.
30. Houssami N, Ciatto S, Ellis I, Ambrogetti D. Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates. Cancer. 2007;109(3):487-95.
31. Park HS, Park S, Cho J, Park JM, Kim SI, Park BW. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy. J Surg Oncol. 2013;107(4):388-92.